Differentiate next-generation GLP-1s by quality of weight loss By Shipra Patel, M.D., Therapeutic Area Lead, Endocrinology, Amy Pace, ScD, Vice President, Biostatistics, Nathan Noakes, Sensor Solutions Director The rise of highly effective glucagon-like peptide-1 receptor agonists (GLP-1s) and multi-agonists has transformed obesity research into a multi-billion-dollar industry with strong momentum and fierce competition
We discuss the development of efficacious AngIV analogs in the treatment of animal models of AD and PD
However, clinical observations suggest that injection may lead to better outcomes, even for gastrointestinal issues
Antioxidant Protection at the Scalp Level: The molecule is recognized for its role in neutralizing free radicals, protecting follicles from oxidative stress that can accelerate premature hair aging